Raynaud’s Phenomenon and Plasma Endothelin: Correlations with Capillaroscopic Patterns in Systemic Sclerosis

Journal of Rheumatology - Tập 36 Số 6 - Trang 1235-1239 - 2009
Alberto Sulli1, Stefano Soldano2,1, Carmen Pizzorni2,1, P. Montagna2,1, M E Secchi2,1, Barbara Villaggio2,1, B. Seriolo2,1, R. Brizzolara2,1, Maurizio Cutolo2,1
1Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Viale Benedetto XV, 6, 16132 Genova, Italy
2From the Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy.

Tóm tắt

Objective.We evaluated endothelin (ET)-1 plasma levels and some clinical measures in patients with primary Raynaud’s phenomenon (PRP), and in patients with systemic sclerosis (SSc) and secondary RP (SRP), in the latter according to their different nailfold videocapillaroscopy (NVC) patterns of microangiopathy (early, active, and late).Methods.Ninety-nine patients with SSc, 49 with PRP, and 45 control subjects were studied. NVC was performed in all patients to distinguish the pattern of microvascular damage, and the morphological alterations were scored by a semiquantitative rating scale. ET-1 plasma levels were evaluated in all individuals by ELISA.Results.ET-1 plasma levels were significantly higher (p = 0.001) in patients with both PRP and SRP, compared to controls. A significant positive correlation (p = 0.03) was found between ET-1 plasma levels and SRP duration, but not between ET-1 plasma levels and PRP duration. Significant correlations were observed in patients with SSc between ET-1 plasma levels and clinical measures (e.g., digital ulcers), as well as the score value of single NVC measures, such as the number of capillaries, “ramified” capillaries, and enlarged capillaries (p < 0.05). Finally, the highest ET-1 plasma levels were found in patients with SSc showing the late pattern of microangiopathy when compared to the early pattern (p = 0.03) and to controls (p = 0.003).Conclusion.Highest ET-1 plasma levels were detected in the more advanced stage of the SSc microangiopathy, namely the late NVC pattern, characterized by capillary loss and increased tissue fibrosis; this might support the involvement of ET-1 in the progression of the microvascular/fibrotic SSc damage.

Từ khóa


Tài liệu tham khảo

10.1002/art.11310

LeRoy, 2001, Criteria for the classification of early systemic sclerosis, J Rheumatol, 28, 1573

LeRoy, 1992, Raynaud’s phenomenon: a proposal for classification, Clin Exp Rheumatol, 10, 485

10.2337/diabetes.51.12.3517

Kowal-Bielecka, 2006, Targeting vascular disease in systemic sclerosis, Endocr Metab Immune Disord Drug Targets, 6, 401, 10.2174/187153006779025793

10.1097/00005344-199800001-00157

10.1046/j.1365-4362.1997.00171.x

10.1136/ard.53.8.506

10.1046/j.1523-1747.2001.01256.x

10.1097/00005344-199800001-00101

10.1007/s10067-004-0987-3

10.1080/030097401753180372

10.1016/S0002-9343(99)80105-3

10.1016/S0923-1811(97)00619-1

10.1136/ard.2003.015289

Maricq, 1983, Microvascular abnormalities as possible predictors of disease subset in Raynaud’s phenomenon and early connective tissue disease, Clin Exp Rheumatol, 1, 195

Cutolo, 2000, Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J Rheumatol, 27, 155

10.1002/art.22636

Carpentier, 1990, Microvasculature in systemic sclerosis, Rheum Dis Clin North Am, 16, 75, 10.1016/S0889-857X(21)01041-3

10.1136/ard.55.8.507

10.1053/sarh.2001.20269

10.1093/rheumatology/keh156

10.1007/BF02230332

Maricq, 1980, Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders, Arthritis Rheum, 23, 183, 10.1002/art.1780230208

10.1016/j.berh.2005.01.001

LeRoy, 1988, Scleroderma (systemic sclerosis); classification, subsets and pathogenesis, J Rheumatol, 15, 202

10.1016/0049-0172(90)90091-S

10.1136/ard.2007.079756

Schmidt, 2007, Assessment of plasma endothelin level measurement in systemic sclerosis, Rev Med Interne, 28, 371, 10.1016/j.revmed.2006.12.019

Yamane, 1992, Significance of plasma endothelin-1 levels in patients with systemic sclerosis, J Rheumatol, 19, 1566

Kahaleh, 1991, Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action, Arthritis Rheum, 34, 978, 10.1002/art.1780340807

10.1097/01.fjc.0000152030.61620.57

Kourembanas, 1991, Hypoxia induces endothelin gene expression and secretion in cultured human endothelium, J Clin Invest, 88, 1054, 10.1172/JCI115367

10.1080/03009740500385584

Vancheeswaran, 1994, Circulating endothelin-1 levels in systemic sclerosis subsets — a marker of fibrosis or vascular dysfunction?, J Rheumatol, 21, 1838

10.1136/ard.2008.097378

10.1093/rheumatology/38.10.992